Bristol-Myers Squibb Co – Lobbying Governance & Transparency

Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:

Lobbying Governance

Overall Assessment	Analysis	Score
Limited	Bristol-Myers Squibb discloses detailed oversight of its political activities—“the Board of Directors of Bristol Myers Squibb has delegated responsibility for oversight of our political activities to our Committee on Directors and Corporate Governance,” which “semi-annually reviews political contributions made by the company and the BMS PAC, and annually reviews the lobbying expenditures reported by certain U.S. trade associations”—and enforces internal controls requiring that “all federal contributions from corporate funds be approved by our Head of Federal Government Affairs” and “all state contributions from corporate funds be approved by our Executive Director, State Government Affairs.” The company also affirms it will “conduct your engagement activities in line with the goals of the Paris Agreement.” However, Bristol-Myers Squibb does not disclose any specific policy or process for aligning its lobbying activities—direct or through trade associations—with its climate commitments, nor does it describe how it assesses and manages the climate‐related positions of its industry partners. View Sources	D

Overall Assessment

Analysis

Score

Limited

Bristol-Myers Squibb discloses detailed oversight of its political activities—“the Board of Directors of Bristol Myers Squibb has delegated responsibility for oversight of our political activities to our Committee on Directors and Corporate Governance,” which “semi-annually reviews political contributions made by the company and the BMS PAC, and annually reviews the lobbying expenditures reported by certain U.S. trade associations”—and enforces internal controls requiring that “all federal contributions from corporate funds be approved by our Head of Federal Government Affairs” and “all state contributions from corporate funds be approved by our Executive Director, State Government Affairs.” The company also affirms it will “conduct your engagement activities in line with the goals of the Paris Agreement.” However, Bristol-Myers Squibb does not disclose any specific policy or process for aligning its lobbying activities—direct or through trade associations—with its climate commitments, nor does it describe how it assesses and manages the climate‐related positions of its industry partners.

View Sources

Lobbying Transparency

Overall Assessment	Analysis	Score
None	No evidence found	E